Chemed financials
$512.05−0.44%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.43B | $2.26B | $2.13B | $2.14B | $2.08B | $1.94B | $1.78B | $1.67B | $1.58B |
| Gross profit | $823.2M | $854.3M | $798.8M | $765.1M | $769.8M | $701.4M | $617.4M | $555.0M | $516.2M | $461.4M |
| Gross margin | 32.5% | 35.1% | 35.3% | 35.8% | 36.0% | 33.7% | 31.9% | 31.1% | 31.0% | 29.3% |
| Operating income | $338.2M | $366.5M | $340.6M | $343.5M | $343.0M | $389.7M | $257.4M | $243.6M | $113.0M | $178.7M |
| Net income | $265.2M | $302.0M | $272.5M | $249.6M | $268.6M | $319.5M | $219.9M | $205.5M | $98.2M | $108.7M |
| Net margin | 10.5% | 12.4% | 12.0% | 11.7% | 12.6% | 15.4% | 11.3% | 11.5% | 5.9% | 6.9% |
| Diluted EPS | $18.34 | $19.89 | $17.93 | $16.53 | $16.85 | $19.48 | $13.31 | $12.23 | $5.86 | $6.48 |
| EBITDA | $403.1M | $429.5M | $401.4M | $402.7M | $402.1M | $446.3M | $302.6M | $282.9M | $149.9M | $215.2M |
| Operating cash flow | $388.3M | $417.5M | $330.3M | $309.9M | $308.6M | $489.3M | $301.2M | $287.1M | $162.5M | $135.4M |
| Free cash flow | $325.5M | $368.0M | $273.4M | $252.6M | $249.9M | $430.5M | $248.2M | $234.3M | $98.2M | $95.6M |
| Diluted shares | 14.5M | 15.2M | 15.2M | 15.1M | 15.9M | 16.4M | 16.5M | 16.8M | 16.7M | 16.8M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $74.5M | $178.3M | $264.0M | $74.1M | $32.9M | $162.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $97.5M | $185.0M | $0.00 |
| Total assets | $1.54B | $1.67B | $1.67B | $1.44B | $1.34B | $1.43B |
| Total liabilities | $558.8M | $549.6M | $560.2M | $643.3M | $719.5M | $533.7M |
| Shareholders' equity | $979.4M | $1.12B | $1.11B | $798.7M | $623.3M | $901.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology